A. Sanduzzi Zamparelli (Naples, Italy), I. Husar (Bucharest , Romania)
Linezolid in the long-term treatment of multidrug-resistent tuberculosis (MDR-TB – case report)
W. Purkarthofer, E. Bitterlich, B. Baumgartner (Voecklabruck, Austria)
|   |
Immunohistochemical staining in detection and localization of mycobacterial tuberculosis in human histological samples (preliminary report)
S. Karimi, F. Mohammadi, M. Bahadori (Tehran, Islamic Republic Of Iran)
| |
A retrospective study of the presentation, diagnosis and outcomes of miliary tuberculosis at a UK centre
R. Gupta, J. Barker, L. Cormican (London, United Kingdom; Dublin, Ireland)
| |
Predictors of residual pleural opacity in tuberculous pleurisy
S. I. Cha, Y. J. Kim, H. J. Jeon, E. J. Kim, C. H. Kim, J. Y. Park, T. H. Jung, S. Y. Lee (Daegu, Republic Of Korea)
| |
Side effects of antituberculosis drugs in treatment of patients with newly detected pulmonary tuberculosis
E. Vaniev, R. Abdullayev, O. Komissarova, I. Vasilyeva (Moscow, Russian Federation)
| |
When do we extend the treatment of tuberculosis (TB) more than 6 months?
J. M. Garcia-Garcia, F. Alvarez-Navascues, M. Garcia-Clemente, J. Allende, J. Ferreiro, M. Martinez-Muñiz, A. Sanchez-Antuña (Aviles, Asturias, Spain)
| |
The epidemiological features of tuberculous pleurisy in a high incidence of tuberculosis region (São Paulo, Brazil)
M. Seiscento, F. S. Vargas, M. J. Rujula, L. Santos, R. K. Sales, S. Bombarda, V. M. Galesi (Sao Paulo, Brazil)
| |
The influence of the epidemic risk factor on advanced processes in adolescents with newly-detected pulmonary TB
L. Rusakova, V. Gergert, V. Firsova, F. Poluektova (Moscow, Russian Federation)
| |
Treatment outcomes under early correction of chemotherapy in adolescents with advanced pulmonary TB
L. Rusakova, V. Gergert, V. Firsova, M. Kobulashvili (Moscow, Russian Federation)
| |
Laryngeal tuberculosis mimicking carcinoma
P. Fsadni, C. Fsadni, B. Caruana Montalto (Gwardamangia, Malta)
| |
What happens when an oral tuberculosis is not treated?
A. E. Erbaycu, Z. Taymaz, F. Tuksavul, A. Afrashi, S. Z. Guclu (Izmir, Turkey)
| |
Medical and social criteria of effectiveness of lung resections in pulmonary tuberculosis (TB)
S. N. Skorniakov, I. J. Motus, S. S. Karskanova, A. S. Maltseva (Ekaterinburg, Russian Federation)
| |
A 30-year-old male with pulmonary tuberculosis associated with echinococcosis and aspergillosis
V. Pencheva, A. Zlatev, O. Georgiev, D. Petrova, T. Mondeshki (Sofia, Bulgaria)
| |
Isoniazid hepatotoxicity associated with treatment of latent tuberculosis in patients on anti-TNF treatment
G. Ongen, I. Ozdemir, B. Musellim, F. Zuhur, S. Erturan, G. Hatemi, V. Hamuryudan (Istanbul, Turkey)
| |
Prevalence of depression in tuberculosis patients in comparison to non-tuberculous family contacts visiting the DOTS Clinic in tertiary care hospital and its correlation with disease pattern
S. Qayyum, N. Rizvi (Karachi, Pakistan)
| |
The level of pleural fluid adenosine deaminase in the diagnosis of tuberculous pleurisy; a cut-off value for our hospital
O. Deniz, E. Tozkoparan, S. Gumus, H. Yaman, F. Ciftci, E. Ucar, I. Kurt, H. Bilgic, K. Ekiz (Ankara, Istanbul, Turkey)
| |
Management of tuberculosis in patients with chronic liver dysfunction
B. Ourari, J. Cherif, S. Toujani, N. M‘hiri, A. Zouaoui, M. Osman Hassen, B. Louzir, J. Daghfous, M. Beji (Tunis, Tunisia)
| |
Outcome of vitamin A & zinc supplementation in the treatment of smear positive pulmonary tuberculosis patients
K.S. Bennor, S. M. A. Mamun (Dhaka, Bangladesh)
| |
Simultaneous infection with nontuberculous and tuberculous mycobacteria
S. Lang, U. Hinzen, I. Nkouatchet, J. Ortmann (Bad Lippspringe, Germany)
| |